Walleye Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78M Sell
12,800
-3,200
-20% -$951K 0.02% 986
2025
Q4
$4.37M Buy
16,000
+4,300
+37% +$1.17M 0.01% 1245
2025
Q3
$3.16M Sell
11,700
-2,400
-17% -$653K 0.01% 1234
2025
Q2
$3.89M Sell
14,100
-3,800
-21% -$1.03M 0.02% 1038
2025
Q1
$4.75M Buy
17,900
+7,900
+79% +$1.95M 0.02% 819
2024
Q4
$2.32M Sell
10,000
-46,400
-82% -$10.7M 0.01% 1649
2024
Q3
$12.4M Buy
56,400
+37,700
+202% +$7.8M 0.03% 576
2024
Q2
$3.68M Sell
18,700
-10,300
-36% -$2.13M 0.01% 1531
2024
Q1
$6.24M Buy
29,000
+13,300
+85% +$2.79M 0.01% 1144
2023
Q4
$3.31M Sell
15,700
-6,900
-31% -$1.47M 0.01% 1395
2023
Q3
$4.52M Sell
22,600
-18,200
-45% -$3.62M 0.01% 1099
2023
Q2
$7.56M Buy
40,800
+38,100
+1,411% +$7.04M 0.03% 522
2023
Q1
$517K Buy
+2,700
New +$488K 0.01% 1693
2019
Q4
Sell
-5,000
Closed -$1.06M 1850
2019
Q3
$1.06M Sell
5,000
-6,100
-55% -$1.27M 0.06% 425
2019
Q2
$2.15M Buy
+11,100
New +$2.05M 0.24% 80

Other funds holding CME

Walleye Capital's CME Position: Q1 2026 in Review

Walleye Capital increased its CME Group (CME) stake by 57,559% in Q1 2026, buying an estimated $19.3M and bringing the position to 65,155 shares worth $19.2M. The position accounts for 0.08% of the portfolio, ranked #204.

Walleye Capital first reported a position in CME in Q3 2018 and has held it in 18 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Walleye Capital held 65,155 shares of CME Group worth $19.2M as of Q1 2026.
  • Walleye Capital bought 65,042 CME Group shares in Q1 2026, an estimated $19.3M.
  • CME Group made up 0.08% of Walleye Capital's portfolio in Q1 2026, its #204 holding.
  • Walleye Capital first reported a position in CME Group in Q3 2018 and has held it in 18 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.